Novo Nordisk boasts 45 million customers using their drug Ozempic, which has caused a revolution in weight-loss treatment.

Ozempic and Wegovy maker Novo Nordisk placed a print ad responding to the Super Bowl spot from competitor Hims & Hers.

Between being a cast member on The Real Housewives of New Jersey, starring in the latest season of the hit competition show ...

But while basic research continues slowly, a flood of Ozempic competitors are rushing to market. Some of them may work even better than Ozempic at causing weight loss. Mounjaro, from a company ...

Novo Nordisk's 2024 earnings exceeded estimates, with strong performance in diabetes, obesity, and rare disease segments.

Shares of Eli Lilly finished Thursday 3% higher despite an earnings report that showed sales of its blockbuster GLP-1 ...

The next FDA Commissioner could solve two big problems with one powerful policy: encourage independent testing of both ...

At the top of that list, unsurprisingly, are Novo Nordisk obesity drugs Ozempic, Rybelsus, and Wegovy, all grouped together as a single drug. Eli Lily's GLP-1 competitor Mounjaro/Zepbound doesn't ...

Trump could either weaken the negotiations in a way that benefits the pharmaceutical industry, or try to achieve even deeper ...

In the head-to-head clinical trial with main GLP-1 agonist competitor Ozempic, Mounjaro was shown to be better at lowering HbA1c and reducing body weight. SURPASS-2 was an open label, 40-week ...

The popular weight-loss drugs known as GLP-1 receptor agonists, which were originally meant to treat diabetes, surged in ...

Tracy McGrady, Shaquille O'Neal, Nikola Vucevic and Steve Francis. "Winner. Ultimate winner, ultimate competitor," Magic coach Jamahl Mosley said of Wagner. "The things he does within a game that ...